June 23rd 2020
February 20th 2020
Jason J. Luke, MD, FACP, discusses predictive biomarkers in metastatic melanoma.
January 7th 2020
Jason J. Luke, MD, FACP, discusses current and emerging treatment paradigms in metastatic melanoma.
July 29th 2015
At the 2015 ASCO Annual Meeting, we witnessed an extraordinary explosion into the general oncology consciousness of the Programmed Death-1: Programmed Death Ligand-1 axis and drugs that target that interaction.